362
Views
0
CrossRef citations to date
0
Altmetric
Correction

Correction

This article refers to:
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

Article title: Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

Authors: Tagliamento M, Genova C, Rijavec E, Rossi G, Biello F, Dal Bello MG, Alama A, Coco S, Boccardo S, and Grossi F

Journal: Expert Opinion on Pharmacotherapy

DOI: https://doi.org/10.1080/14656566.2018.1540591

When the above article was first published online, incorrect data was included in Table 1. This has now been corrected as shown below.

Table 1. Relevant efficacy and safety data of LUX-Lung 8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.